BCL2 and metabolic dysfunction-associated steatotic liver disease: –↓ apoptosis population in a dose-dependent manner compared to NAFLD-modeled cells;–↓ caspase-3 protein expression and slightly upregulated antiapoptotic protein Bcl-2.